The function of the zinc finger transcription factor GATA3 was studied in a newly established, conditionally immortal cell line derived to represent auditory sensory neuroblasts migrating from the mouse otic vesicle at embryonic day E10.5. The cell line, US/VOT-33, expressed GATA3, the bHLH transcription factor NeuroD and the POU-domain transcription factor Brn3a, as do auditory neuroblasts in vivo. When GATA3 was knocked down reversibly with antisense oligonucleotides, NeuroD was reversibly down-regulated. Auditory and vestibular neurons form from neuroblasts that express NeuroD and that migrate from the antero-ventral, otic epithelium at E9.5 -10.5. On the medial side, neuroblasts and epithelial cells express GATA3 but on the lateral side they do not. At E13.5 most auditory neurons express GATA3 but no longer express NeuroD, whereas vestibular neurons express NeuroD but not GATA3. Neuroblasts expressing NeuroD and GATA3 were located in the ventral, otic epithelium, the adjacent mesenchyme and the developing auditory ganglion. The results suggest that auditory and vestibular neurons arise from different, otic epithelial domains and that they gain their identity prior to migration. In auditory neuroblasts, NeuroD appears to be dependent on the expression of GATA3. q
Introduction
The aim of this work was to explore the function of the zinc finger transcription factor GATA3 during early stages of neural development in the mammalian auditory system. GATA3 is expressed in selected cells of the nervous system and in numerous other tissues during development, including the placenta, liver, kidney and thymus (Oosterwegel et al., 1992; George et al., 1994; Ng et al., 1994; Pata et al., 1999; Nardelli et al., 1999; Van Doorninck et al., 1999; Lim et al., 2000; Asnagli et al., 2002) . Its expression pattern is highly conserved between vertebrates. Homozygous null mutants for GATA3 suffer poor development of the central nervous system, disrupted haematopoiesis and internal bleeding, and die by embryonic day 11-12 (E11-12; Pandolfi et al., 1995) . GATA3 is also essential for development of the inner ear (Karis et al., 2001) . It is expressed in the otic placode and at some stage in all the sensory epithelia but it is particularly persistent in the epithelial and neural components of the auditory system Lawoko-Kerali et al., 2002) . In man, mutations in GATA3 have been linked to hypoparathyroidism, sensorineural deafness and renal anomaly syndrome (HDR) (Van Esch et al., 2000; Muroya et al., 2001) . There are clear indications of function in the development of auditory innervation. GATA3 is expressed in auditory but not vestibular ganglion neurons in the mouse at E14 Lawoko-Kerali et al., 2002) . The null mutant appears to lose auditory ganglion neurons selectively (Karis et al., 2001 ) and the efferent nerve supply fails to target the ear, suggesting that GATA3 regulates molecules associated with neural differentiation and guidance (Karis et al., 2001 ).
During development of the otocyst the auditory and vestibular neuroblasts are amongst the first cell types to be specified (Hemond and Morest, 1991; Hossain and Morest, 2000; Fekete and Wu, 2002) . They migrate from the anteroventral epithelium at E9.5-10.5, simultaneously downregulating their epithelial cytokeratin. Their differentiation depends upon the two bHLH transcription factors, neurogenin 1 (ngn1) and NeuroD. In null mutants for ngn1, both auditory and vestibular neurons are absent, showing that this gene is essential for the differentiation of all inner ear sensory neurons (Ma et al., 1998) . Ma et al. (1998) suggest that NeuroD and b3-tubulin are part of the same regulatory cascade downstream of ngn1. In null mutants for NeuroD, migration of both auditory and vestibular neuroblasts is compromised, although there is a significantly greater depletion of auditory ganglion neurons (Liu et al., 2000; Kim et al., 2001) . Furthermore, the neurotrophin receptors TrkB and TrkC, normally present in the ganglia, are not expressed. The POU domain transcription factor Brn3a also regulates neuronal survival in the inner ear and there is evidence that it selectively regulates expression of TrkC .
To explore the function of GATA3 we established a conditionally immortal cell line from the ventral otocyst of an Immortomouse at E10.5. The Immortomouse is a transgenic animal that harbours a temperature-sensitive variant of the large 'T' antigen from the SV40 virus (Jat et al., 1991) . Conditional immortalisation allows us to study specific cell types through defined time windows in development, meeting the need to maintain cell phenotype under immortalizing conditions (Bongarzone et al., 1996; . Conditionally immortal cell lines have been established from the entire otocyst at E9.5 (Barald et al., 1997) , the organ of Corti at E13 , early postnatal utricular maculae (Zheng et al., 1998; Lawlor et al., 1999) and postnatal organs of Corti (Kalinec et al., 1999) . We required a new cell line to reflect as closely as possible the genetic profile of auditory neuroblasts. Cells established from embryonic and early post-natal tissue retain their ability to follow key aspects of the normal differentiation pathway in vitro when the T-antigen is inactivated . Furthermore, cells derived from the embryonic brain of the Immortomouse differentiate structurally and functionally following transplantation in vivo (Virley et al., 1999) , suggesting that the T-antigen does not alter them irreversibly.
In this paper we report experiments on an inner ear cell line that indicate a functional link between GATA3 and NeuroD. In this context we describe the expression patterns of these factors in vivo. The results suggest that auditory and vestibular ganglion neuroblasts emerge from different domains within the ventral otocyst, defined by the expression patterns for GATA3 and NeuroD. Following migration, auditory and vestibular ganglion neurons can be distinguished by their reciprocal expression of GATA3 and NeuroD. We conclude that GATA3 transiently and selectively regulates NeuroD in auditory neuroblasts and that it confers specific properties on auditory ganglion neurons.
Results

Isolation and selection of cell lines
To establish a cell line representing the GATA3-positive, migrating neuroblasts we removed the ventral parts of Immortomouse otocysts at E10.5, following the methods of Li et al. (1978) , and selected for clones that expressed GATA3 but not cytokeratin. The expression of GATA3 was maintained in ventral otic explants after 10 days in culture under immortalizing conditions. Its expression appeared to be stable and independent of extrinsic factors, so we remained confident that derived cell lines would represent cells that expressed GATA3 during normal development. From a total of 60 clones obtained by dissociation and subsequent limiting dilution, 8 that were positive for GATA3 were selected for further characterisation. Each clone was then cultured at 33 and at 39 8C and immunolabelled with antibodies to GATA3 and pan-cytokeratin. Virtually all cells were positive for GATA3 although there was wide variation in intensity between cells (Fig. 1A -D) . Cytokeratin expression was variable between clones. In some clones it was expressed in all cells but in others it was absent. One clone expressing GATA3 but not cytokeratin was named US/VOT-33 after the University of Sheffield, the Ventral OTocyst and the clone number. Given the developmental timing and the expression patterns for GATA3 and cytokeratin in vivo we reasoned that US/VOT-33 should have been derived from a population of sensory neuroblasts.
Characterisation of the auditory neuroblast cell line US/VOT-33
Proliferation and morphology
Proliferation of US/VOT-33 was dependent on the T-antigen although it continued for at least 4 days following transfer to differentiating conditions. The influence of the T-antigen was expected to disappear within 2 days but it should be noted that the cell line was derived from an otocyst at E10.5 and that auditory and vestibular ganglion neurons do not normally stop dividing until E11.5-14.5 (Ruben, 1967) . US/VOT-33 cells were readily dissociated with trypsin and adhered to tissue culture dishes within 30-45 min. At 39 8C they formed a uniform and confluent culture. At 33 8C GATA3 was expressed at various levels in all cells but at 39 8C the labelling intensity was higher and more uniform (Fig. 1A -D) . The lack of cytokeratin (Fig. 1E) suggested that the cells were not epithelial and most of them labelled with TUJ1 for b3-tubulin at 33 8C and at 39 8C (Fig. 1F) . This result was consistent with a neuronal phenotype. The cells did not display the polygonal morphology and rounded nuclei normally seen in cultured epithelial cells and their actin filaments traversed the cell in parallel bundles similar to stress fibres.
Immunoblotting for selected markers
Selected markers were used to define US/VOT-33 at 33 8C and after 14 days at 39 8C (Fig. 2) . GATA3 protein was expressed under both conditions as expected from the immunolabelling (Fig. 1A,B) . NeuroD was detected at relatively high levels at 33 8C compared to those after 14 days at 39 8C, which is consistent with the profile observed in vivo (see later). Brn3a was present under both conditions with some evidence for up-regulation at 39 8C. It should be an effective marker for auditory and vestibular neurons . b3-tubulin (TUJ1) was also expressed under both conditions, consistent with the immunofluorescence data (Fig. 1F) . US/VOT-33 thus expressed a coherent set of factors associated with auditory sensory neurons.
Suppression of GATA3
To investigate the function of GATA3 in the cell line US/VOT-33 it was knocked down with antisense oligonucleotides. Cells were transferred to 39 8C, treated immediately with optimal concentrations of antisense and screened 36 and 60 h later (Fig. 3) . Immunolabelling of cultured cells and immunoblotting of protein extracts showed that translation of GATA3 was blocked by the antisense oligonucleotide at 36 h and that after 60 h, without further antisense treatment, GATA3 protein reappeared. NeuroD behaved in the same way. It was detectable by immunoblotting in control samples, absent after 36 h with antisense to Gata3 and then detectable again after 60 h. ab-tubulin was used to compare the protein loading on the gels. Treatment with sense oligonucleotides (S) resulted in a detectable decrease in the expression of GATA3 and NeuroD but this effect was less pronounced than that observed with the antisense oligonucleotide. The untreated control (C) involved addition of an equivalent volume of MEM/FCS and was used to compare the normal levels of GATA3 expression under the same experimental conditions. The results were observed in three separate experiments with different populations of cells and they indicated that the presence of NeuroD protein was dependent upon GATA3.
The link between GATA3 and NeuroD was unexpected so for further confirmation the experiment was repeated with antisense morpholinos (MO). Protein extracts and immunoblotting again showed that decreases in the levels of GATA3 were associated with decreases in NeuroD (Fig. 4) . The level of b3-tubulin was slightly lower than that in the sequence-specific (S) and standard control (C) samples. We then investigated an auditory epithelial cell line that expresses both GATA3 and NeuroD. Normal hair cells express GATA3 and NeuroD (Liu et al., 2000; Kim et al., 2001 ). Thus we conducted the same experiment with GATA3 MO on the cell line UB/OC-1, which was derived from auditory tissue at E13.5 and which expresses a number of hair cell markers . In this case GATA3 was knocked down but NeuroD and b3-tubulin remained unaffected (Fig. 4) . The blots for ab-tubulin suggested that these results were not due to differences in protein loading. No changes in the expression of GATA3 were observed when either of the cell lines was treated with the specific control MO.
Correlation between GATA3 and NeuroD in vivo
To explore the link between GATA3 and NeuroD further we studied their expression patterns in vivo. The otic placode labelled with antibodies for GATA3 at E8.5 but not The blot for abtubulin was used as a loading control. The apparent downregulation of NeuroD is consistent with the down-regulation between E10.5 and E13.5 that was observed in auditory ganglion cells during normal development. Fig. 3 . Cellular immunolabelling for GATA3 in US/VOT-33 at 39 8C after incubation with antisense oligonucleotides (AS) sense oligonucleotides (S) and normal media (C). The antisense blocked expression of Gata3. The corresponding western blots for GATA3, NeuroD and ab-tubulin showed that GATA3 was blocked by the antisense oligonucleotide at 36 h but it had recovered by 60 h. NeuroD was not detected when GATA3 was blocked but it was also present after 60 h. Tubulin was used to compare the protein loading on the gels. Scale bar ¼ 100 mm.
for NeuroD, although a few cells close to the ventral edge were positively labelled for NeuroD but not for GATA3 (not shown). At E9.5 a small number of cells in the dorsal region of the otocyst were labelled for both factors. The number of cells labelled for NeuroD was much higher in the ventral region of the otocyst where there was clear overlap with GATA3 ( Fig. 5A,B) . By contrast, neurons within the trigeminal ganglion labelled for NeuroD but not for GATA3 ( Fig. 5B) .
At E10.5 a section through the ventral half of the otocyst revealed several different regions based upon labelling for GATA3 (Fig. 5C ). These included an intensely labelled lateral region (between arrows 1 and 4 in Fig. 5C ), a relatively weakly labelled medial region (between arrows 2 and 4) and an unlabelled anterior/lateral region (between arrows 1 and 2). This pattern was observed consistently in at least 5 different animals. Corresponding results for NeuroD in consecutive sections revealed the zone of migrating neuroblasts along the anterior edge of the otocyst (Fig. 5D ). Put together, the labelling patterns provided evidence for several epithelial boundaries relating to neuroblast migration. The first was defined by the edge of intense labelling for GATA3, which marked the lateral limit of the zone of migration (arrow 1 in Fig. 5C ). The second was defined by the edge of weaker expression for GATA3 in the anterior region within the zone of migration (arrow 2 in Fig. 5C ). The third was defined by the medial margin of the zone of migration, which lay within the region weakly labelled for GATA3 (arrow 3 in Fig. 5C ). The zone of neuroblast migration thus contained one region that was labelled for GATA3 and another that was not. At E11.5 GATA3 was expressed in a sub-population of the cells expressing NeuroD (Fig. 5E -F) . Although the identity of this sub-population is unknown it is likely to be the precursor of the auditory ganglion, which is represented most prominently in this plane and level of section. At E13.5 the auditory ganglion was clearly positive for GATA3 but the vestibular ganglion was unlabelled (Fig. 6A) . These results are consistent with the idea that two populations of neurons are derived from specific, predefined domains of otic epithelium. However, whereas at earlier stages neuroblasts expressing GATA3 also expressed NeuroD, few did so by E13.5. In contrast, most vestibular ganglion neurons were labelled for NeuroD at this stage (Fig. 6B) . The majority of auditory and vestibular ganglion neurons were thus distinguishable at this stage by their reciprocal expression of GATA3 and NeuroD.
Given the detection of NeuroD expression in hair cells (Liu et al., 2000; Kim et al., 2001) we looked through entire sets of serial sections of whole otocysts labelled for NeuroD protein. However, apart from a few isolated cells we did not observe obvious labelling in the developing sensory epithelia up to E14.5.
Double labelling for GATA3 and NeuroD
The antibody to GATA3 only tolerated very light fixation with acetone and alcohol and we were unable to use it for double labelling. Thus we applied antibodies against bgalactosidase and NeuroD to cryostat sections of heterozygous Gata3 knockout mice that had one Gata3 allele replaced by an nlsLacZ reporter gene (see Van Doorninck et al., 1999) . These antibodies should label the nuclei in cells expressing GATA3 and NeuroD, respectively. At the relevant stages there is a close correlation between the gene expression pattern for GATA3 (Karis et al., 2001) and the corresponding antibody labelling (Lawoko-Kerali et al., 2002) . Double-labelling revealed cell nuclei that were positive either for NeuroD or GATA3 or both (Fig. 7) . Some cells labelled for GATA3 within the otic epithelium were also labelled for NeuroD but the majority was not. However, all cells labelled for GATA3 outside the epithelium were also labelled for NeuroD. Previous studies suggested that in the ventral region of the otocyst the only GATA3-expressing cells lying outside the otic epithelium were neuroblasts (Lawoko-Kerali et al., 2002) . The preparation and labelling of sections was difficult and we were unable to obtain serial sections to allow a meaningful total count of double-labelled cells. The largest number of GATA3-expressing cells outside of the otic epithelium in a single section was 35 from a total of 180 that labelled for NeuroD. Considerable variation was expected with respect to the level and plane of section through the otocyst. and UB/OC-1 with antisense (AS) morpholinos and a specific control sequence (S) for Gata3. A GeneTools standard control (C) was also included. Cells were transferred to 39 8C, treated immediately and screened 48 h later. For US/VOT-33 the results were similar to those observed with antisense oligonucleotides although there was no apparent loss of GATA3 in the specific control. b3-tubulin was also screened and was detected at slightly lower levels with the antisense Morpholinos. In the OC-1 cell line the antisense Morpholino to Gata3 caused little detectable change in NeuroD or b3-tubulin.
In summary, double-labelled cells were found within the otic epithelium, adjacent to its outer surface and in the region of the developing auditory and vestibular ganglia.
Discussion
The results provide strong evidence that auditory and vestibular ganglion neurons are derived from specific domains of the ventral otic epithelium (Fig. 8) . Neuroblasts migrate from epithelial populations that either do or do not express GATA3. We suggest that these populations are directly related to neurons in the auditory ganglion, which also express GATA3, and to those in the vestibular ganglion, which do not. NeuroD is expressed by almost all migrating neuroblasts (Liu et al., 2000; Kim et al., 2001) but it is down-regulated in auditory ganglion neurons after their migration. Furthermore, experiments in vitro suggest that GATA3 sustains NeuroD transiently in these neuroblasts during migration. . In a consecutive section, NeuroD labelled similar populations of cells to those labelled for GATA3 in A, but also labelled cells in the trigeminal ganglia (arrow). (C) At E10.5 the distribution of relatively intense label for GATA3 in the ventral half of the otocyst was observed on the lateral side (between arrows 1 and 4). The anterior sector was divided into two parts. The first (between arrows 1 and 2) was virtually unlabelled for GATA3 but the second (between arrows 2 and 3) was weakly labelled. The sector between arrows 3 and 4 was also labelled weakly. Anterior is to the lower right and lateral is to the upper right of the image. (D) In a consecutive section to that shown in C, NeuroD was labelled in migrating neuroblasts on the ventral, anterior surface. The zone of migrating cells (between arrows 1 and 3) did not overlap with that labelled intensively for GATA3. However, it included lateral cells that were unlabelled for GATA3 (between arrows 1 and 2) and medial cells that were weakly labelled (between arrows 2 and 3). (E) At E11.5 weak labelling for GATA3 was observed in epithelial cells within the otocyst (arrow) and in migrating neuroblasts (arrowheads). Anterior is to the right and lateral is to the top of the image. (F) In a consecutive section to that shown in E, NeuroD was observed only in migrating neuroblasts and not in the epithelial cells (arrow). At this stage and in this section, most of the neuroblasts that were labelled for both GATA3 and NeuroD lay adjacent to a part of the otic epithelium that was weakly labelled for GATA3. However, to the lateral side there was a smaller population of cells labelled for NeuroD but not for GATA3 (*) and they lay adjacent to a region of otic epithelium also unlabelled for GATA3. Scale bar ¼ 50 mm.
Differentiation of auditory and vestibular ganglion neurons
In a morphological study of the mouse ear at E12.5, Sher (1971) described medial and lateral populations of aggregating neuroblasts as precursors of the auditory and vestibular ganglia, respectively, which do not separate morphologically until about E14.5. This topology is supported to some extent by the expression pattern for GATA3 (Karis et al., 2001; Fritzsch et al., 2002) . Our results show that neuroblasts expressing NeuroD migrate from a medial location of the ventral otic epithelium, in which GATA3 is expressed, and from a lateral location, in which GATA3 is absent. Cells expressing both GATA3 and NeuroD, or NeuroD alone, were found in corresponding areas of the epithelium, the intermediate regions of the mesenchyme and in developing ganglia. Since the developing auditory ganglion expresses GATA3 whereas the vestibular ganglion does not, we suggest that the two populations may be specified before they leave the otic epithelium. Our results provide evidence that the two populations of neuroblasts are specified either side of a mediallateral boundary within the otic epithelium, as proposed by Fekete and Wu (2002) . Lineage studies could provide definitive evidence for this separation (Brigande et al., 2000; Lang and Fekete, 2001 ) but, even in the chick, it is technically difficult to infect cells at a sufficiently early stage (Lang and Fekete, 2001) . Our counts of the relative numbers of neuroblasts labelled and unlabelled for GATA3 are hard to interpret in terms of the total numbers of mature neurons. Vestibular neuroblasts migrate slightly earlier than those that will form the auditory ganglion and the relative levels of proliferation outside the epithelium are not known (see reviews by Rubel and Fritzsch, 2002; Fritzsch, 2003) . The majority of auditory and vestibular ganglion neurons stop dividing at E11.5 -14.5 and E11.5 -E12.5, respectively (Ruben, 1967) .
GATA3 may play a key role in specifying auditory ganglion neurons, as suggested for other neuronal subtypes, including serotonergic neurons of the raphe nucleus in the mouse ) and a sub-population of ventral spinal cord interneurons in the chick (Karunaratne et al., 2002) . However, we know little of the genes that might be regulated by GATA3. Karis et al. (2001) suggested that it may regulate ephrins and eph receptors, specifically the EphB2 receptor. Interestingly, during conditional differentiation of the cochlear cell line, UB/OC-1, temporal expression profiles of an unknown eph receptor and several semaphorins clustered with that of GATA3 . Unfortunately, the task of confirming targets of GATA3 in the null mutant is complicated by several problems. The mutant suffers a severely deformed otocyst, we have no means of distinguishing specific epithelial domains within the zone of neural migration and no markers to distinguish different populations of neuroblasts. Auditory ganglion neurons, but not vestibular ganglion neurons, clearly express GATA3 in the heterozygous nls LacZ null mouse (Karis et al., 2001 ), a result confirmed by antibody labelling Lawoko et al., 2002) . They are absent in the homozygous nls LacZ null mouse but the residual ganglion, presumed to be vestibular, is clearly labelled. Thus it is not possible to identify cells that would normally have expressed GATA3. Karis et al. (2001) suggested that there may be another, equivalent zinc finger transcription factor equivalent to GATA3 in the vestibular neurons. An equivalent for NeuroD may similarly be expressed during later development of auditory ganglion neurons (Fig. 8) .
Regulation of NeuroD by GATA3
Regulation of NeuroD by GATA3 is not obvious from their expression patterns because these factors are coexpressed only transiently in a specific population of neuroblasts. However, null mutants for ngn1 (Ma et al., 1998) , NeuroD (Liu et al., 2000; Kim et al., 2001 ) and GATA3 (Karis et al., 2001 ) provide a clue. The absence of ngn1 results in complete loss of auditory and vestibular neurons. The loss of NeuroD, however, leads to slightly different effects on the two ganglia, with losses of about 80 and 95% of vestibular and auditory ganglion neurons, respectively. This, at least in part, is due to failure of neuroblast migration from the epithelium (Liu et al., 2000) . Our in vitro data shows that GATA3 was required to maintain the function of NeuroD, which is consistent with the observation that the GATA3 null mouse loses the auditory ganglion selectively (Karis et al., 2001) .
The nature of the GATA3-NeuroD interaction is not clear. The promoter sequence for NeuroD contains one potential binding site for GATA3 at bases 411 -416 (Xu and Murphy, 1998) so it is possible that it is regulated directly. In any case, the differential dependence that we observed in neuroblasts and hair cells implies that there are interactions with one or more co-factors. In vertebrates, the functions of GATA factors are modulated by the cofactors FOG1 and FOG2 (Friend of GATA; Chang et al., 2002) . In Drosophila, the FOG-related protein U-shaped can convert the fly GATA factor Pannier from a transcriptional activator to a repressor (Haenlin et al., 1997; Garcia-Garcia et al., 1999; ). FOG1 was expressed in both of the cell lines that we studied, so unless its function is Fig. 7 . Immunolabelling for NeuroD (A),B) and GATA3 (C),(D) in E10.5 heterozygous Gata3 knockout mice that had one Gata3 allele replaced by an nlsLacZ reporter gene. Panels (A,C,E) show low magnification images of the same section through the otocyst labelled for NeuroD (A) in green), GATA3 (C) in red) and both factors (E). Panels (B,D,F) show a different section at higher magnification. Double-labelled cells were located both inside (arrows) and outside (arrowheads) the otic epithelium. Two nuclei (*) located at the edge of the otic epithelium may have been about to enter the mesenchyme. Nuclei in (E) and (F) are labelled with DAPI (blue). Scale bars ¼ 100 mm. regulated post-translationally it seems unlikely to account for the differential effects on NeuroD.
Expression of NeuroD in neurons and hair cells
Our results show that NeuroD is down-regulated in auditory ganglion neurons following migration and that it was undetectable with antibodies by E13.5. Evidence based upon a lacZ reporter suggests that it is not down-regulated until 5-6 days later (Kim et al., 2001) . The difference in timing may reflect post-transcriptional regulation or the fact that lacZ produces a more sensitive and persistent label. Nevertheless, down-regulation of NeuroD protein occurs during an important phase of inner ear development and is not observed in the vestibular ganglion. In conjunction with the data from the null mutant, it implies that NeuroD does not have identical functions in the two neuronal populations. Interestingly, the cell line VOT-33 behaves in a similar way because it also down-regulates NeuroD during culture under differentiating conditions in vitro.
Expression studies suggest that NeuroD is expressed in significant numbers of hair cells in vestibular epithelia from E13.5, auditory epithelia from E14.5 (Kim et al., 2001 ) and in animals 3 months old (Liu et al., 2000) . However, the existence of morphologically normal hair cells in NeuroD null mutants provides evidence that their differentiation is independent of NeuroD (Kim et al., 2001 ). The defects observed in the auditory sensory epithelium (Liu et al., 2000) are more likely to be secondary to the failures of neuronal migration and differentiation. It remains possible that NeuroD confers some unidentified property on hair cells but any such function appears to be independent of GATA3. Our results show that in the 'hair cell' line UB/OC-1, inhibition of GATA3 has no effect on NeuroD. This is consistent with normal development because GATA3 is down-regulated in hair cells shortly after they are born Lawoko-Kerali et al., 2002) . The expression patterns require careful analysis since our immunolabelling results suggest that NeuroD protein may be absent from hair cells or present only at very low levels. Interestingly, in the ngn1 null mutant, which may also lack NeuroD, there are about 40% fewer hair cells but those that remain appear to differentiate normally .
In conclusion, this work highlights significant differences in the expression of GATA3 and NeuroD between developing neurons of the auditory and vestibular ganglia throughout critical phases of neural development in the mammalian inner ear. The specific functions of these transcription factors may be responsible for spatial segregation and differential innervation of the six, closely located mechanosensory organs.
Experimental procedures
Ventral otocyst dissection and derivation of cell lines
Homozygous male Immortomice were time-mated with wild-type C57Bl/6 female mice to produce heterozygous offspring. The day of the vaginal plug was established as embryonic day 0.5 (E0.5). Animals were killed by cervical dislocation, in accordance with UK Home Office regulations. Otocysts were removed from E10.5 embryos under sterile conditions and then dissected to isolate the ventral region. Ventral otocyst explants from 3 -5 embryos were pooled in double-chambered plastic dishes in which the first chamber contained 0.15 ml of pre-warmed Neuman and Tytell serumless medium (NT; Life Technologies, Paisley, Scotland) supplemented with 20% heat-inactivated fetal calf serum (FCS; Life Technologies; Li et al., 1978) . The second chamber surrounded the outer margin of the first chamber and contained 0.5 ml pre-warmed sterile water to prevent evaporation medium from the first chamber. Explants were maintained for 10-12 days in medium containing 50 U/ml g-interferon (gIFN) at 33 8C to ensure expression of the immortalising gene. Some explants were immunolabelled to confirm the sustained expression of GATA3 in vitro and to indicate the type of tissue morphology that should be selected for further selection, dissociation and isolation. This helped to enrich the target cell population at an early stage. NeuroD is expressed in all neuroblasts. GATA3 (shaded nuclei) is restricted to the medial neuroblasts destined to form the auditory ganglion. When the neuroblasts differentiate, GATA3 remains expressed in the auditory ganglion and NeuroD is down-regulated, whereas in the vestibular ganglion the opposite occurs. This suggests that equivalent genes may be present to serve the function of GATA3 in vestibular neurons and NeuroD in auditory neurons. It also suggests that the function of NeuroD is subtly different in the 2 neuronal phenotypes. The diagram represents the suggestion that auditory ganglion neurons express GATA3 and emerge from a region of the otic epithelium that also expresses GATA3.
Cell culture and conditional expression of T antigen
Epithelial cells were further enriched by selective adhesion (Freshney, 1994) . They were cultured in 35 mm Petri dishes (Falcon range, Becton Dickinson, Oxford, England) and, once confluent, washed twice with Hanks Balanced Salt Solution without Ca 2þ and Mg 2þ (Sigma) before dissociation in 0.25% trypsin (Sigma). They were then plated at a density of 10 cells/well in 96-well plates (Corning Incorporation life Sciences, Acton, MA, USA) in a 1:1 mixture of NT/FCS/gIFN medium and Minimal Essential Medium with Earle's salts and 1% Glutamax I (MEM; Life Technologies) in order to wean them to MEM/FCS/gIFN. Resultant clones were cultured at 33 8C and then re-cloned at densities of 0.3, 0.5, and 1 cell/well in flat-bottomed, 96-well plates containing MEM/FCS/gIFN at 33 8C.
Clones were passaged and then transferred into progressively larger diameter wells within 24, 12 and 6-well plates (Corning) and later cultured in 25 and 75 cm 2 flasks in MEM/FCS/gIFN. Clones were named after the University of Sheffield (US), the source from the ventral otocyst (VOT) and the clone number. Selected clones were expanded, split and cultured under proliferating (33 8C with gIFN) and differentiating (39 8C without gIFN) conditions. We refer to these conditions with reference to the temperature. Cells at 33 8C were fed with fresh medium every 3-4 days and replated once every week in either 35 mm-diameter dishes or 75 cm 2 flasks (Falcon range, Becton Dickinson, Oxford, England). Cells at 39 8C were fed with fresh medium at least once every week and cultured for up to 20 days without being replated.
Cryostat sectioning
Homozygous wild-type C57Bl/6 mice were time-mated and sacrificed as described above. Embryos were dissected in a mixture of cold MEM and 30% sucrose in phosphate buffered saline (PBS) and inner ear tissues were mounted anterio-posteriorly in embedding medium (Cryo-M-Bed, Bright Instrument Company Ltd), before being frozen in liquid iso-pentane cooled under liquid nitrogen. 10 mm thick serial sections were cut on a cryostat onto gelatinecoated multiwell slides for immunolabelling. The tissues were stored at -80 8C prior to and after cryostat sectioning.
Immunolabelling
Cell cultures were seeded at a density of 1 £ 10 5 in 35 mm dishes or 1 £ 10 4 in 2 cm 2 , 4-well Sonic-seal slides (Nunc, Life Technologies) at 33 8C for 2-3 days or at 39 8C for up to 14 days. All immunolabelling was done at room temperature. Cells were washed twice in PBS, fixed in a 50:50 mixture of cold acetone/methanol (v/v) on ice for 10 min and air-dried for 5 min. Frozen inner ear tissue was sectioned to a thickness of 10 mm before being placed on 12-well slides (BDH). The sections were fixed in a 1:1 mixture of acetone:methanol on ice for 1 -2 min and air dried for 5 min. The edges of the 35 mm dishes/sections were marked with an ImmEdgee pen (Vector Laboratories) to use a minimal amount of antibody solution. Cells/sections were rehydrated with PBS and subsequently incubated for 90 min with the following primary mouse monoclonal antibodies; GATA3 (clone HG3-31, Santa Cruz Biotechnology; diluted 1:200), pan-cytokeratin (C2562, Sigma; diluted 1:100) and b3-tubulin (TUJ1, MMS435P, Cambridge Bioscience for Babco, California; diluted 1:500), and the rabbit polyclonal antibody Pax2 (Cambridge Bioscience for Babco, California, diluted 1:150). Cells were then washed with PBS for 3 £ 5 min, incubated for 90 min either with a fluorescent secondary antibody or with a biotinylated secondary antibody. The latter was then processed with the ABC reagent for 30 min according to the Vector Laboratories protocol. Visualization of the staining was done using peroxidase in the VIP Kit (Vector Laboratories) for 2-5 min. In controls, purified mouse immunoglobulins were applied at similar concentrations to the primary antibodies. Cell cultures were mounted either in anti-fade solution (Molecular Probes) or in glycergel jelly (BDH) and the results analysed and recorded with a Leica DMIRB microscope equipped with a Zeiss Axiocam digital imaging system. 4.5. Double-labelling for b-Gal and Neuro-D Frozen sections were taken from whole nlsLacZ/gata3 heterozygous null embryos fixed with 4% paraformaldehyde and processed for b-galactosidase. They were permeabilized with 0.1% Triton X-100 (Sigma) in PBS and dried for 10 min. A blocking solution of 5% donkey serum in PBS was applied for 10 min before incubation with primary antibody. A purified monoclonal antibody to b-Galactosidase (Promega-Z3781) was applied at a dilution of 1:300 and an anti-NeuroD, goat polyclonal antibody ) was used at a dilution of 1:100. After 2 h incubation, the sections were washed three times and then incubated with fluorescein (FITC)-conjugated AffiniPure Donkey Anti-Goat IgG (1:200) and rhodamine red anti-mouse IgG (1:300). Sections were then washed twice with PBS. DAPI (4,6-Diamidino-2-phenylindole, 1:100) was added to the last wash for 2 min to label the nuclei. The sections were mounted with SlowFade Light Antifade Kit from Molecular Probes (S-7461).
Immunoblotting
Protein and nuclear extracts were prepared from cells at 33 8C for 2-4 days in culture and at 39 8C for 2-14 days in culture. Cells for protein samples were extracted in 200 ml protein extraction buffer (150 mM NaCl, 1% NP40, 0.1% SDS, 50 mM Tris, pH 7.4) and the extracts centrifuged at 10; 000 £ g for 10 min at 4 8C. The supernatants were collected and protein concentrations determined with the BCA method (Pierce, Chester England). Cells for nuclear preparations were extracted in 700 ml nuclear extraction buffer (1 M KCl, 1 M MgCl 2 .6H 2 O, 1 M DTT, 2.5 M sucrose, 85%w/v, 0.5 M Hepes, pH7.5) and the extracts centrifuged at 800 g for 5 min at 4 o C. Pellets were resuspended in 1 ml 1 £ NB and left to stand on ice for 20 min. Membranes were gently disrupted in a Wheaton glass homogenizer, underlayed with 200 ml underlay solution (0.1 £ NB, 30% sucrose) and thereafter centrifuged at 800 g for 15 min at 4 8C. The supernatants were discarded and pellets resuspended in 100-200 ml 1 £ NB. Both cell and nuclear extracts were diluted with 2 £ sample buffer (10% 2-mercaptoethanol, 4% SDS, 20% glycerol, 0.125 M Tris, pH 6.8), aliquoted into 100-200 ml volumes and stored frozen at 2 80 8C.
Samples were thawed and boiled at 95 8C for 3 -4 min before loading onto 6-14% acrylamide gels for electrophoresis. The gels were transferred onto nitrocellulose or Immobilone-P (Millipore) membranes using a transfer tank run at 60-120 mA (Voltage , 10 mV) for 1 -2 h. The membranes were incubated in 2.5% Bovine serum albumin (Sigma) and 2.5% non-fat dried milk in 50 ml PBS overnight to block non-specific binding. They were then washed briefly with PBS before incubation for 1-2 h at room temperature with one of the following primary antibodies; GATA3 (Santa Cruz Biotechnology, clone HG3-31; diluted 1:50), NeuroD goat polyclonal antibody (clone 19, Santa Cruz Biotechnology; diluted 1:100), Brn3a rabbit polyclonal antibody (PRB242C, Cambridge Bioscience for Babco, California, diluted 1:400), b3-tubulin mouse monoclonal antibody (TUJ1, MMS435P, Cambridge Bioscience for Babco, California; diluted 1:500) and tubulin Ab-4 mouse monoclonal antibody (MS-719-P1, NeoMarkers, Fremont, CA; diluted 1:500). Membranes were washed with PBS for 3 £ 5 min and incubated for 1 -2 h at room temperature with the corresponding HRPconjugated secondary antibody (Sigma) and for 5 -10 min with Supersignal chemiluminescent substrate (Pierce, Rockford, IL). Blots were exposed to X-ray films for 1 -30 min.
GATA3 phosphorothioate oligonucleotides
Antisense (AS) oligodeoxynucleotides were designed against the translational start region of GATA3 and consisted of 21-mer analogues (Hattori et al., 1996) . A complimentary sense (S) sequence was designed and used as a control. Untreated cells (C) were also used as controls. The oligodeoxynucleotides were synthesised with a phosphorothioate backbone to improve resistance to endonucleases. The sequences, manufactured by MWGBiotech UK LTD, were as follows: GATA3 'AS' DNA; 5 0 -CGC AGT CAC CTC CAT GTC CTC-3 0 ; GATA3 'S1' DNA; 5 0 -GAG GAC ATG GAG GTG ACT GCG-3 0 ; and GATA3 'S2' DNA; 5 0 -CTC CTG TAC CTC CAC TGA CGC-3 0 .
Cells were cultured in 35 mm dishes or in 75 cm 2 flasks in MEM/FCS and transiently transfected with various concentrations of either GATA3 AS or sense oligonucleotides mixed with Lipofectamine/Plus Reagent (Life Technologies) for up to 72 h at 33 and 39 8C. Optimal concentrations were determined and the following concentrations selected: 1 £ 10 5 cells/35 mm dish, 0.4 mM GATA3 AS/S, 6 ml Lipofectamine, 6 ml Plus Reagent and 300 ml MEM or 5 -8 £ 10 5 cells/75 cm 2 flask, 1.5 mM GATA3 AS/S, 20 ml Lipofectamine, 20 ml Plus Reagent and 600 ml MEM. To assess the effect of the AS, GATA3 treated AS/S cells and non-treated cells were immunolabelled or immunoblotted with appropriate primary antibodies. Trypan blue staining was used to assess cell viability.
GATA3 antisense morpholinos
Morpholino oligonucleotides (MO) were designed and supplied by GeneTools, LLC. The antisense MO sequences were 25-mer long and designed to block translation by binding to the translation initiation complex. A sequencespecific control (S) consisted of 4 mis-match pairs along the GATA3 antisense sequence. A GeneTools standard control oligonucleotide was used as a general, non-specific control (C). The MO sequences were as follows: GATA3 (AS) MO: 5 0 -CGGCTGGTCCGCAGTCACCTCCATG-3 0 ; 4-mis mGATA3 (S) MO: 5 0 -CGGCaGGTCgGCAGTgACCTg-CATG-3 0 . Cells were cultured in 35 mm dishes or 75 cm 2 flasks in MEM/FCS as described for the phosphorothioate AS samples above. The MO-DNA was dissolved in distilled water to a concentration of 0.5 mM stock solution. It was allowed to complex with ethoxylated polyethylenimine (EPEI), a delivery solution designed to increase cellular uptake of MO-DNA. Cells were incubated in MO AS/S/C diluted in MEM to a final concentration of 1.4-2.1 mM for 3 h at 33 8C. After the 3 h incubation 10% FCS was added and fresh medium was changed after 24 h. To assess the effect of the MO, cells were immunolabelled or immunoblotted for the following primary antibodies; GATA3, NeuroD, b3-Tubulin and Tubulin Ab-4. Trypan blue staining was used to assess cell viability.
